.
Organon has a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergy and asthma. We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed. We are here for her health.
Consilient Health is a pharmaceutical company, focused on bringing medicines that address unmet clinical needs to patients in the United Kingdom and Europe. The Company is headquartered in Ireland, with operations in UK, Sweden and additional partnerships in Europe. Our current focus is women’s health, endocrinology, bone health and urology.
In the UK our current portfolio includes a wide range of products in three main therapeutic areas: women’s health, urology and endocrinology. Within endocrinology, we have a focus on bone health with a range of prescription medicines that address vitamin D deficiency. In women’s health, Consilient Health offers a range of hormone replacement therapy (HRT treatments) that are designed to suit different women. In urology we have a medicine for bladder pain syndrome/interstitial cystitis.
We continue to focus on building our range of medicines. For more information visit www.consilienthealth.com
Exeltis UK - Rethinking healthcare. Rethinking women’s health.
Established in 2022 to bring Exeltis products to the UK market. Exeltis - parent company of Exeltis UK and part of the Insud Pharma family - aspires to be a leader in Women’s Health. By constantly seeking innovative treatments and devices to improve women’s health and well-being, Exeltis aims to support women throughout every stage of their sexual and reproductive life.
EXECOR2022006 October 2022
Gedeon Richter have a presence in over 100 countries worldwide and have been working to change lives for the better since 1901. We are one of the few companies in the world to offer a comprehensive portfolio for women; our R&D team continue to innovate and extend our gynaecological, fertility and osteoporosis portfolio, aiming to address women’s healthcare needs in these areas. Our ambition is to help women achieve theirs.
April 2022, UK-GED-2200035
TriOn Pharma is a dynamic UK-based Nutraceutical, Pharmaceutical, and Medical Device company, committed to pioneering innovative, high-quality, and cost-effective products to enhance health and well-being. As an ethical pharmaceutical firm, we collaborate with the NHS to optimize drug budgets without compromising quality.
